Citron Research’s tweet suggesting President-elect Donald Trump begin his war on drug pricing with pharmacy benefit manager Express Scripts caused the company’s stock to fall as much as 9 percent ...

) from Hold to Sell, while reducing the price target from $93 to $61. Hill believes that there could be downside risk of 11 percent to the stock, from the current levels. "Given the acrimony between ...

They're the two biggest pharmacy benefits managers in the world, and they compete against each other every day. While CVS Health boasts a higher market cap thanks to its retail pharmacies, Express ...

Valeant Pharmaceuticals Inc. sustained hits on several fronts on Thursday after CVS Health Corp. and Express Scripts dropped Philidor from their networks in a sign the fallout from the drugmaker's ...